Investeringsoversigt

7775 investments

Titel Sort descending	Periode	Program
Flowplan - Intelligent filter management	2020 - 2020	Innobooster
Flowplan - Intelligent filter management Period 2020 - 2020 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 32.26 Invested 400.000 Budget 1.2 mill. Partners Flowplan ApS People Flowplan ApS Read more about the project
Flowplan - Intelligent filterhåndtering med IoT	2019 - 2019	Innobooster
Flowplan - Intelligent filterhåndtering med IoT Period 2019 - 2019 Region Region Hovedstaden Program Innobooster Area Produktion, Materialer, Digitalisering og IKT Investment Percentage 32.65 Invested 320.000 Budget 980.000 Partners Flowplan IVS People Flowplan ApS Read more about the project
Flowreaktor til Grafen Produktion	2023 - 2024	Innobooster
Flowreaktor til Grafen Produktion Period 2023 - 2024 Region Program Innobooster Area Ikke defineret Investment Percentage 35 Invested 673.313 Budget 1.9 mill. Partners Danish Graphene ApS People Read more about the project
Fluidan - Prototype og Validering	2015 - 2016	Innobooster
Fluidan - Prototype og Validering Period 2015 - 2016 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 50 Invested 457.000 Budget 914.000 Partners FLUIDAN ApS People FLUIDAN ApS Read more about the project
Fluispotter - Klinisk validering af en ny, innovativ metode til automatiseret 24-timers blodprøvetagning	2016 - 2020	Grand Solutions
Fluispotter - Klinisk validering af en ny, innovativ metode til automatiseret 24-timers blodprøvetagning Period 2016 - 2020 Region Region Hovedstaden Program Grand Solutions Area Biotek, Medico og Sundhed Investment Percentage 74.85 Invested 5.8 mill. Budget 7.7 mill. Partners Region Hovedstaden, Rigshospitalet, Region Hovedstaden, Rigshospitalet, Hovedstaden, Herlev Hospital, Fluisense ApS People FLUISENSE ApS Read more about the project
FluoCure FluoCure - taking cancer surgery to cellular precision with targeted photothermal therapy	2023 - 2027	Grand Solutions
FluoCure FluoCure - taking cancer surgery to cellular precision with targeted photothermal therapy Period 2023 - 2027 Region Program Grand Solutions Area Ikke defineret Investment Percentage 54.83 Invested 27.0 mill. Budget 49.2 mill. Cancer is the second leading cause of death globally with 15 million new cases diagnosed every year. Surgery is a cornerstone in the treatment, and is currently used in 45% of all cancer patients. Despite surgery, cancer recurs in approx. half of the patients. While surgery holds enormous potential, it is greatly underserved. FluoCure aims to develop and clinically test the FluoCure drug. It is composed of a peptide and a fluorophore bound together by a linker. The peptide binds to urokinase plasminogen activator receptor (uPAR), highly specific for tumors, and the fluorophore enables precise thermal ablation and visualization of cancer cells. FluoCure will disrupt cancer surgery with a cancer-targeted photothermal therapy—bringing cellular precision to surgery. The ambition is to test the FluoCure drug in a phase I/II trial in high-grade glioma patients. The patients will directly benefit from a lower recurrence rate and higher survival rate. The society will be able to offer advanced treatment and reduce recurrence-related costs. Following successful clinical translation, the FluoCure drug will be used for other indications. The potential is immense, as more than 80% of the solid cancers express uPAR. This ambitious venture will only be possible with a multidisciplinary team of experts in peptides (UCPH-CHEM), fluorophores (UCPH-FLUO), imaging & cancer models (UCPH-CMI), neurosurgery & clinical trials (RH-Neuro), and business development & regulatory affairs (FluoGuide). Partners University of Copenhagen, University of Copenhagen, University of Copenhagen, Copenhagen University Hospital (Rigshospitalet), FluoGuide A/S People Read more about the project
FluoGuide: Optical probe to guide cancer surgeons	2017 - 2021	Grand Solutions
FluoGuide: Optical probe to guide cancer surgeons Period 2017 - 2021 Region Region Hovedstaden Program Grand Solutions Area Biotek, Medico og Sundhed Investment Percentage 74.27 Invested 10.3 mill. Budget 13.9 mill. Partners Copenhagen University Hospital (Rigshospitalet), Copenhagen University Hospital (Rigshospitalet), University of Copenhagen, University of Copenhagen, University of Copenhagen, Curasight Aps, Fluoguide IVS, FluoGuide A/S, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52 People KU - SUND - PANUM KBH N Read more about the project
FluoRAS Fluorescence Water Quality Sensor for Control of Land-Based Aquaculture Systems	2021 - 2023	Grand Solutions
FluoRAS Fluorescence Water Quality Sensor for Control of Land-Based Aquaculture Systems Period 2021 - 2023 Region Region Hovedstaden Program Grand Solutions Area Energi, Klima og Miljø Investment Percentage 75 Invested 6.4 mill. Budget 8.6 mill. Partners Technical University of Denmark, Oxyguard A/S People Danmarks Tekniske Universitet Read more about the project
Fluorescence-free fermentation monitoring with time-gated Raman spectroscopy	2024 - 2026	Industrial Researcher
Fluorescence-free fermentation monitoring with time-gated Raman spectroscopy Period 2024 - 2026 Region Program Erhvervsforsker Area Ikke defineret Investment Percentage 61.52 Invested 828.000 Budget 1.3 mill. Løbende målinger af fermenteringsprocesser med konventionel kontinuert bølgelængde Raman spektroskopi, er meget begrænset grundet en stærk fluorescerende baggrund. Vi foreslår et tidsbegrænset Raman instrument baseret på pulserende excitations lasere, som vil fjerne den fluorescerende baggrund fra Raman målingerne, og demonstrere brugen af denne teknologi til overvågning af fermentering. Partners Technical University of Denmark, Lightnovo ApS People Read more about the project
Flydende rottelokkemad, kommunikation og mekanik til mekanisk rottefælde	2023 - 2024	Innobooster
Flydende rottelokkemad, kommunikation og mekanik til mekanisk rottefælde Period 2023 - 2024 Region Program Innobooster Area Ikke defineret Investment Percentage 35 Invested 446.299 Budget 1.3 mill. Partners Captivis Aps People Read more about the project
FocalX Automated Exterior Car Damage Engine	2022 - 2022	Innobooster
FocalX Automated Exterior Car Damage Engine Period 2022 - 2022 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 35 Invested 488.250 Budget 1.4 mill. Partners FocalX ApS People FocalX ApS Read more about the project
FocalX: Remote car damage detection for all	2023 - 2024	Innobooster
FocalX: Remote car damage detection for all Period 2023 - 2024 Region Program Innobooster Area Ikke defineret Investment Percentage 35 Invested 754.688 Budget 2.2 mill. Partners FocalX ApS People Read more about the project
Foliar biopesticides for protecting wheat against Septoria tritici blotch	2022 - 2025	Industrial Researcher
Foliar biopesticides for protecting wheat against Septoria tritici blotch Period 2022 - 2025 Region Region Hovedstaden Program Erhvervsforsker Area Ikke defineret Investment Percentage 100 Invested 1.1 mill. Budget 1.1 mill. Partners University of Copenhagen, CHR HANSEN A/S People CHR HANSEN A/S Read more about the project
Folkesundhedsvidenskaber til fitnesscenter	2022 - 2023	Innobooster
Folkesundhedsvidenskaber til fitnesscenter Period 2022 - 2023 Region Region Nordjylland Program Innobooster Area Ikke defineret Investment Percentage 100 Invested 150.000 Budget 150.000 Partners MYHEART ApS People MYHEART ApS Read more about the project
Fondaparinux syntese	2018 - 2018	Innobooster
Fondaparinux syntese Period 2018 - 2018 Region Region Syddanmark Program Innobooster Area Ikke defineret Investment Percentage 29.75 Invested 495.062 Budget 1.7 mill. Partners Hepoligo Solutions Aps People Hepoligo Solutions ApS Read more about the project